Infectious Disease Diagnostics Market by Product (Reagents, Assays, Instrument), Test (Laboratory, POC), Technology (Immunodiagnostics, Microbiology, PCR, NGS, INAAT), Disease (COVID-19, Hepatitis, HAI, HIV, Influenza), End User - Global Forecast to 2026

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2              MARKETS COVERED.. 31
1.2.3              YEARS CONSIDERED FOR THE STUDY
1.3             CURRENCY
1.4             LIMITATIONS
1.5             STAKEHOLDERS
1.6             SUMMARY OF CHANGES

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
2.2             RESEARCH APPROACH
・       FIGURE 1.. INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH
DESIGN METHODOLOGY
2.2.1              SECONDARY DATA
2.2.1.1            KEY DATA FROM SECONDARY SOURCES
2.2.2              PRIMARY DATA
2.2.2.1            KEY DATA FROM PRIMARY SOURCES
2.2.2.2            KEY INDUSTRY INSIGHTS
・       FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION
2.3             MARKET SIZE ESTIMATION
2.3.1              BOTTOM-UP APPROACH
・       FIGURE 3 INFECTIOUS DISEASE DIAGNOSTICS MARKET: BOTTOM-UP APPROACH
・       FIGURE 4................. CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2              TOP-DOWN APPROACH.. 40
・       FIGURE 5.. INFECTIOUS DISEASE DIAGNOSTICS MARKET: TOP-DOWN APPROACH
2.4             MARKET BREAKDOWN AND DATA TRIANGULATION
・       FIGURE 6.......................... DATA TRIANGULATION METHODOLOGY
2.5             ASSUMPTIONS FOR THE STUDY
2.6             RISK ASSESSMENT
・       TABLE 1..... RISK ASSESSMENT: INFECTIOUS DISEASE DIAGNOSTICS MARKET
2.7             COVID-19 HEALTH ASSESSMENT
2.8             COVID-19 ECONOMIC ASSESSMENT
2.9             ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
・       FIGURE 7................. CRITERIA IMPACTING THE GLOBAL ECONOMY
・       FIGURE 8............. RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.10          ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
IN THE INFECTIOUS DISEASE DIAGNOSTICS MARKET

3.... EXECUTIVE SUMMARY

・       FIGURE 9 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
・       FIGURE 10........... INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION)
・       FIGURE 11 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE,
2021 VS. 2026 (USD MILLION)
・       FIGURE 12..... INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)
・       FIGURE 13 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION,
2021 VS. 2026 (USD MILLION)

4.... PREMIUM INSIGHTS

4.1             INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
・       FIGURE 14............. THE RISING ADOPTION OF POC DIAGNOSTICS IS EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD
4.2             INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION)
・       FIGURE 15....... REAGENTS, KITS, AND CONSUMABLES SEGMENT TO COMMAND THE LARGEST SHARE OF THE MARKET, BY PRODUCT & SERVICE, IN 2021
4.3             INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION)
・       FIGURE 16. IMMUNODIAGNOSTICS TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
4.4             INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2021 VS. 2026
・       FIGURE 17.. DIAGNOSTIC LABORATORIES DOMINATE THE END-USER MARKET

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 18.. INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1              DRIVERS
5.2.1.1            GLOBAL PREVALENCE OF INFECTIOUS DISEASES AND ONSET OF COVID-19
5.2.1.2            RISING FOCUS ON R&D AND FUNDING IN INFECTIOUS DISEASE DIAGNOSTICS
5.2.1.3            GROWING AWARENESS FOR EARLY DISEASE DIAGNOSIS IN DEVELOPING COUNTRIES
5.2.1.4            RISING TECHNOLOGICAL ADVANCEMENTS IN INFECTIOUS DISEASE DIAGNOSTICS
5.2.1.5            SHIFT IN FOCUS FROM CENTRALIZED LABORATORIES TO DECENTRALIZED
POC TESTING
5.2.2              RESTRAINTS
5.2.2.1            UNFAVORABLE REIMBURSEMENT SCENARIO
5.2.3              OPPORTUNITIES
5.2.3.1            GROWTH OPPORTUNITIES IN GROWING ECONOMIES
5.2.4              CHALLENGES
5.2.4.1            CHANGING REGULATORY LANDSCAPE
5.2.4.2            OPERATIONAL BARRIERS
5.2.5              COVID-19 IMPACT ANALYSIS
5.3             PRICING ANALYSIS
・       TABLE 2.... PRICING ANALYSIS OF INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS (2021)
5.4             PATENT ANALYSIS
5.4.1              POLYMERASE CHAIN REACTION
5.4.2              IMMUNODIAGNOSTICS.. 63
5.5             VALUE CHAIN ANALYSIS
・       FIGURE 19..... VALUE CHAIN ANALYSIS OF THE INFECTIOUS DISEASE DIAGNOSTICS MARKET
5.6             SUPPLY CHAIN ANALYSIS
・       FIGURE 20.......................................... SUPPLY CHAIN ANALYSIS
5.7             ECOSYSTEM ANALYSIS
5.8             PORTER’S FIVE FORCES ANALYSIS
・       TABLE 3 INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE
FORCES ANALYSIS
5.8.1              THREAT FROM NEW ENTRANTS
5.8.2              THREAT FROM SUBSTITUTES
5.8.3              BARGAINING POWER OF BUYERS
5.8.4              BARGAINING POWER OF SUPPLIERS
5.8.5              COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.9             PESTLE ANALYSIS
5.10          REGULATORY LANDSCAPE
5.10.1            NORTH AMERICA
5.10.1.1          US
5.10.1.2          CANADA
5.10.2            EUROPE
5.10.3            ASIA PACIFIC
5.10.3.1          CHINA
5.10.3.2          JAPAN
5.10.3.3          INDIA
5.10.4            LATIN AMERICA
5.10.4.1          BRAZIL
5.10.4.2          MEXICO
5.10.5            MIDDLE EAST
5.10.6            AFRICA
5.11          TRADE ANALYSIS
5.11.1            TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
・       TABLE 4............. IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS,
BY COUNTRY, 2016─2020 (USD MILLION)
・       TABLE 5............. IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS,
BY COUNTRY, 2016─2020 (TONS)
5.11.2            TRADE ANALYSIS FOR CULTURE MEDIA
・       TABLE 6............. IMPORT DATA FOR CULTURE MEDIA, BY COUNTRY,
2016─2020 (USD MILLION)
・       TABLE 7............. IMPORT DATA FOR CULTURE MEDIA, BY COUNTRY,
2016─2020 (TONS)
5.12          TECHNOLOGY ANALYSIS
5.13          YC–YCC SHIFT
・       FIGURE 21................ YC–YCC SHIFT FOR THE INFECTIOUS DISEASE DIAGNOSTICS MARKET

6.... INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

6.1             INTRODUCTION
・       TABLE 8 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
6.2             REAGENTS, KITS, AND CONSUMABLES
6.2.1              REPEAT PURCHASE OF REAGENTS, KITS, AND CONSUMABLES
DRIVES THE MARKET GROWTH
・       TABLE 9... INFECTIOUS DISEASE DIAGNOSTICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION). 75
6.3             INSTRUMENTS
6.3.1              INCREASING NEED FOR FASTER & ACCURATE TEST RESULTS TO
PROPEL THE MARKET GROWTH
・       TABLE 10................ KEY PRODUCTS IN THE INSTRUMENTS MARKET
・       TABLE 11.......... INFECTIOUS DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION). 77
6.4             SOFTWARE & SERVICES
6.4.1              NEED TO DELIVER ACCURATE AND TIMELY ANALYSIS OF DIAGNOSTIC TESTS
・       TABLE 12............ INFECTIOUS DISEASE DIAGNOSTICS SOFTWARE & SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION)

7.... INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TYPE OF TESTING

7.1             INTRODUCTION
・       TABLE 13... INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TYPE OF TESTING,
2019–2026 (USD MILLION)
7.2             LABORATORY TESTING
7.2.1              OUTBREAK OF COVID-19 DRIVES DEMAND FOR LAB TESTS
・       TABLE 14... LABORATORY TESTING MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3             POC TESTING
7.3.1              THE INCREASING ADOPTION OF POC TECHNOLOGIES DRIVES THE
GROWTH OF THIS SEGMENT
・       TABLE 15....... POC TESTING MARKET, BY REGION, 2019–2026 (USD MILLION)

8.... INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY

8.1             INTRODUCTION
・       TABLE 16............. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
8.2             IMMUNODIAGNOSTICS
8.2.1              RISING PREVALENCE OF INFECTIOUS DISEASES AND DEMAND FOR
COVID-19 DIAGNOSTICS DRIVE MARKET GROWTH
・       TABLE 17............ INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS,
BY REGION, 2019–2026 (USD MILLION)
8.3             POLYMERASE CHAIN REACTION
8.3.1              THE GROWING USE OF RT-PCR IN COVID-19 TESTS IS A MAJOR GROWTH DRIVER FOR THIS SEGMENT
・       TABLE 18. INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR, BY REGION,
2019–2026 (USD MILLION)
8.4             CLINICAL MICROBIOLOGY
8.4.1              GROWING ADOPTION BY RESEARCHERS AND ACADEMIA IS EXPECTED
TO DRIVE MARKET GROWTH
・       TABLE 19 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CLINICAL MICROBIOLOGY, BY REGION, 2019–2026 (USD MILLION)
8.5             ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY
8.5.1              COST-BENEFITS OF INAAT DRIVE DEMAND FOR THE TECHNOLOGY
・       TABLE 20 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INAAT, BY REGION,
2019–2026 (USD MILLION)
8.6             DNA SEQUENCING & NGS
8.6.1              INCREASING FOCUS ON PERSONALIZED MEDICINE IS A GROWTH
DRIVER FOR THIS SEGMENT
・       TABLE 21...... INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DNA SEQUENCING
& NGS, BY REGION, 2019–2026 (USD MILLION)
8.7             DNA MICROARRAYS
8.7.1              GROWING AWARENESS ABOUT ADVANCED TECHNOLOGIES TO
DRIVE MARKET GROWTH
・       TABLE 22...... INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DNA MICROARRAYS,
BY REGION, 2019–2026 (USD MILLION)
8.8             OTHER TECHNOLOGIES
・       TABLE 23... INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES,
BY REGION, 2019–2026 (USD MILLION)

9.... INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE

9.1             INTRODUCTION
・       TABLE 24. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE,
2019–2026 (USD MILLION)
9.2             COVID-19
9.2.1              HIGH AND GROWING CASE PREVALENCE ENSURES DEMAND FOR
COVID-19 DIAGNOSTICS
・       TABLE 25........................... DISTRIBUTION OF CASES BY COUNTRY
・       TABLE 26 COVID-19 DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 27 COVID-19 DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
・       TABLE 28...... COVID-19 DIAGNOSTICS MARKET, BY METHOD, 2019–2026 (USD MILLION)
9.3             HUMAN IMMUNODEFICIENCY VIRUS
9.3.1              THE HIGH PREVALENCE OF HIV WILL DRIVE THE MARKET GROWTH
FOR THIS SEGMENT
・       TABLE 29. HIV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 30........ HIV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
9.4             HOSPITAL-ACQUIRED INFECTIONS
9.4.1              THE RISING BURDEN OF MRSA INFECTIONS IS A KEY FACTOR
DRIVING THE MARKET GROWTH FOR THIS SEGMENT
・       TABLE 31. HAI DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 32........ HAI DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
9.5             HEPATITIS
9.5.1              THE GLOBAL PREVALENCE OF HEPATITIS IS A KEY FACTOR DRIVING
MARKET GROWTH
・       TABLE 33 HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 34 HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
・       TABLE 35..... HEPATITIS DIAGNOSTICS MARKET, BY METHOD, 2019–2026 (USD MILLION)
9.6             CHLAMYDIA TRACHOMATIS GENITAL INFECTIONS AND GONORRHEA
9.6.1              CT/NG INFECTIONS ARE THE MOST COMMON STDS
・       TABLE 36.... CT/NG DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 37.... CT/NG DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
9.7             HUMAN PAPILLOMA VIRUS
9.7.1              TECHNOLOGICAL ADVANCEMENTS SUCH AS RAPID HPV DIAGNOSTICS
TO DRIVE THE MARKET GROWTH FOR THIS SEGMENT
・       TABLE 38 HPV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 39....... HPV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
9.8             TUBERCULOSIS
9.8.1              THE INCREASING BURDEN OF TB GLOBALLY TO DRIVE THE MARKET
GROWTH OF THIS SEGMENT
・       TABLE 40......... TUBERCULOSIS DIAGNOSTICS MARKET, BY REGION,
2019–2026 (USD MILLION)
・       TABLE 41......... TUBERCULOSIS DIAGNOSTICS MARKET, BY REGION,
2019–2026 (MILLION TESTS)
・       TABLE 42........ TUBERCULOSIS DIAGNOSTICS MARKET, BY METHOD,
2019–2026 (USD MILLION)
9.9             INFLUENZA
9.9.1              RISING FOCUS ON CONTAINING THE SPREAD OF INFLUENZA
・       TABLE 43..... INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 44............... INFLUENZA DIAGNOSTICS MARKET, BY REGION,
2019–2026 (MILLION TESTS)
・       TABLE 45.... INFLUENZA DIAGNOSTICS MARKET, BY METHOD, 2019–2026 (USD MILLION)
9.10          OTHER INFECTIOUS DISEASES
・       TABLE 46.... OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION,
2019–2026 (USD MILLION)

10.. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER

10.1          INTRODUCTION
・       TABLE 47....... INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.2          DIAGNOSTIC LABORATORIES
10.2.1            INCREASING OUTSOURCING TO DIAGNOSTIC LABORATORIES FOR
REDUCED COSTS DRIVES MARKET GROWTH
・       TABLE 48............ INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
10.3          HOSPITALS & CLINICS
10.3.1            HOSPITALS & CLINICS SHOW INCREASING ADOPTION RATE OF INFECTIOUS DISEASE DIAGNOSTIC TOOLS
・       TABLE 49............ INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HOSPITALS
& CLINICS, BY REGION, 2019–2026 (USD MILLION)
10.4          ACADEMIC RESEARCH INSTITUTES
10.4.1            FOCUS ON DEVELOPING INNOVATIVE TESTS DRIVES MARKET GROWTH
・       TABLE 50............ INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
10.5          OTHER END USERS
・       TABLE 51... INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER END USERS,
BY REGION, 2019–2026 (USD MILLION)

11.. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION

11.1          INTRODUCTION
・       TABLE 52.. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION,
2019–2026 (USD MILLION)
11.2          NORTH AMERICA
・       FIGURE 22.... NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
・       TABLE 53...... NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 54...... NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 55...... NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 56...... NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 57...... NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)
11.2.1            US
11.2.1.1          US DOMINATES THE MARKET IN NORTH AMERICA AND GLOBALLY
・       TABLE 58........ US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2019–2026 (USD MILLION)
・       TABLE 59........ US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・       TABLE 60........ US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE,
2019–2026 (USD MILLION)
・       TABLE 61.. US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.2.2            CANADA
11.2.2.1          FOCUS ON AFFORDABLE TESTS DRIVES THE MARKET GROWTH
・       TABLE 62. CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2019–2026 (USD MILLION)
・       TABLE 63. CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 64. CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 65. CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3          EUROPE
・       TABLE 66. EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 67. EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2019–2026 (USD MILLION)
・       TABLE 68. EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 69. EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 70. EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.1            GERMANY
11.3.1.1          GERMANY HOLDS THE LARGEST SHARE OF THE MARKET IN EUROPE
・       TABLE 71.. GERMANY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2019–2026 (USD MILLION)
・       TABLE 72.. GERMANY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 73.. GERMANY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 74.. GERMANY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.2            ITALY
11.3.2.1          ADOPTION OF ADVANCED DIAGNOSTIC TECHNOLOGIES TO DRIVE
MARKET GROWTH IN ITALY
・       TABLE 75..... ITALY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2019–2026 (USD MILLION)
・       TABLE 76..... ITALY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 77..... ITALY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 78..... ITALY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.3.3            FRANCE
11.3.3.1          RISING R&D EXPENDITURE IN FRANCE
・       TABLE 79. FRANCE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2019–2026 (USD MILLION)
・       TABLE 80. FRANCE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 81. FRANCE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 82. FRANCE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.4            SPAIN
11.3.4.1          HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS INDICATE FAVORABLE PROSPECTS FOR MARKET GROWTH
・       TABLE 83.... SPAIN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2019–2026 (USD MILLION)
・       TABLE 84.... SPAIN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 85.... SPAIN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 86.... SPAIN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.3.5            UK
11.3.5.1          THE INCREASING NUMBER OF ACCREDITED DIAGNOSTIC LABORATORIES
PROPELS MARKET GROWTH IN THE UK
・       TABLE 87........ UK: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 88........ UK: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・       TABLE 89........ UK: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE,
2019–2026 (USD MILLION)
・       TABLE 90.. UK: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.3.6            REST OF EUROPE
・       TABLE 91...... ROE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 92...... ROE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・       TABLE 93...... ROE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE,
2019–2026 (USD MILLION)
・       TABLE 94 ROE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.4          ASIA PACIFIC
・       FIGURE 23....... APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
・       TABLE 95..... APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 96..... APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 97..... APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 98..... APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 99..... APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.4.1            CHINA
11.4.1.1          GROWING ACCESS TO MODERN HEALTHCARE AND OUTBREAK OF COVID-19
・       TABLE 100.. CHINA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2019–2026 (USD MILLION)
・       TABLE 101.. CHINA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 102.. CHINA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 103.. CHINA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.4.2            JAPAN
11.4.2.1          UNIVERSAL HEALTHCARE REIMBURSEMENT POLICY TO DRIVE MARKET
GROWTH IN JAPAN
・       TABLE 104.. JAPAN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2019–2026 (USD MILLION)
・       TABLE 105.. JAPAN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 106.. JAPAN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 107.. JAPAN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.4.3            INDIA
11.4.3.1          INCREASING PRIVATE & PUBLIC INVESTMENTS IN THE COUNTRY’S HEALTHCARE SYSTEM WILL DRIVE MARKET GROWTH
・       TABLE 108... INDIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 109... INDIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 110... INDIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 111... INDIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)
11.4.4            REST OF ASIA PACIFIC
・       TABLE 112 ROAPAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 113 ROAPAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 114 ROAPAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 115 ROAPAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5          LATIN AMERICA
11.5.1            RISING DISEASE PREVALENCE AND HEALTHCARE EXPENDITURE HAVE DRAWN FOREIGN PLAYERS TO LATAM MARKETS.. 143
・       TABLE 116...... LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 117...... LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 118...... LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 119...... LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION). 145
11.6          MIDDLE EAST & AFRICA
11.6.1            RISING ACCESS TO ADVANCED TECHNOLOGIES AND GROWING INVESTMENTS WILL SUPPORT MARKET GROWTH
・       TABLE 120.... MEA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 121.... MEA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・       TABLE 122.... MEA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 123.... MEA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)

12.. COMPETITIVE LANDSCAPE

12.1          OVERVIEW
・       FIGURE 24............... KEY STRATEGIES IN THE INFECTIOUS DISEASE DIAGNOSTICS MARKET (2018–2021)
12.2          REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
・       FIGURE 25.. REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS IN THE INFECTIOUS DISEASE DIAGNOSTICS MARKET
12.3          MARKET SHARE ANALYSIS
・       FIGURE 26.. INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER (2020)
12.3.1            INFECTIOUS DISEASE DIAGNOSTICS MARKET RANKING, BY DISEASE TYPE
12.3.1.1          HEPATITIS
・       TABLE 124 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HEPATITIS,
BY KEY PLAYER, 2020
12.3.1.2          HIV
・       TABLE 125 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HIV,
BY KEY PLAYER, 2020
12.3.1.3          HPV
・       TABLE 126 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HPV,
BY KEY PLAYER, 2020
12.3.1.4          INFLUENZA
・       TABLE 127 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INFLUENZA,
BY KEY PLAYER, 2020
12.3.1.5          COVID-19
・       TABLE 128 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COVID-19,
BY KEY PLAYER, 2020
12.4          COMPANY EVALUATION QUADRANT
12.4.1            STARS
12.4.2            EMERGING LEADERS
12.4.3            PERVASIVE PLAYERS
12.4.4            PARTICIPANTS
・       FIGURE 27. INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT, 2020
12.5          COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020)
12.5.1            PROGRESSIVE COMPANIES
12.5.2            STARTING BLOCKS.. 154
12.5.3            RESPONSIVE COMPANIES
12.5.4            DYNAMIC COMPANIES.. 154
・       FIGURE 28. INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020)
12.6          PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF TOP PLAYERS
・       FIGURE 29. PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF TOP PLAYERS
IN THE INFECTIOUS DISEASE DIAGNOSTICS MARKET
12.7          COMPETITIVE SCENARIO.. 156
12.7.1            MARKET EVALUATION MATRIX, 2018–2020
12.7.2            INFECTIOUS DISEASE DIAGNOSTICS: PRODUCT LAUNCHES & APPROVALS
・       TABLE 129...................... KEY PRODUCT LAUNCHES & APPROVALS
12.7.3            INFECTIOUS DISEASE DIAGNOSTICS: DEALS
・       TABLE 130............................................................ KEY DEALS
12.7.4            INFECTIOUS DISEASE DIAGNOSTICS: OTHER DEVELOPMENTS
・       TABLE 131...................................... OTHER KEY DEVELOPMENTS

13.. COMPANY PROFILES

13.1          KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, RIGHT TO WIN)*
13.1.1            ABBOTT LABORATORIES
・       TABLE 132.............. ABBOTT LABORATORIES: BUSINESS OVERVIEW
・       FIGURE 30.... ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
13.1.2            F. HOFFMANN-LA ROCHE
・       TABLE 133............ F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
・       FIGURE 31.. F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2020)
13.1.3            BIOMÉRIEUX SA
・       TABLE 134........................ BIOMÉRIEUX SA: BUSINESS OVERVIEW
・       FIGURE 32.............. BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020)
13.1.4            THERMO FISHER SCIENTIFIC
・       TABLE 135........ THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
・       FIGURE 33........ THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
13.1.5            DANAHER CORPORATION
・       TABLE 136............ DANAHER CORPORATION: BUSINESS OVERVIEW
・       FIGURE 34.. DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
13.1.6            QUIDEL CORPORATION
・       TABLE 137............... QUIDEL CORPORATION: BUSINESS OVERVIEW
・       FIGURE 35..... QUIDEL CORPORATION: COMPANY SNAPSHOT (2020)
13.1.7            HOLOGIC
・       TABLE 138................................. HOLOGIC: BUSINESS OVERVIEW
・       FIGURE 36...................... HOLOGIC: COMPANY SNAPSHOT (2020)
13.1.8            PERKINELMER
・       TABLE 139.......................... PERKINELMER: BUSINESS OVERVIEW
・       FIGURE 37................ PERKINELMER: COMPANY SNAPSHOT (2020)
13.1.9            BECTON, DICKINSON AND COMPANY
・       TABLE 140............ BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
・       FIGURE 38............ BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
13.1.10         SIEMENS HEALTHINEERS AG
・       TABLE 141........ SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
・       FIGURE 39.. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
13.1.11         DIASORIN S.P.A
・       TABLE 142........................ DIASORIN S.P.A: BUSINESS OVERVIEW
・       FIGURE 40.............. DIASORIN S.P.A: COMPANY SNAPSHOT (2020)
13.1.12         BIO-RAD LABORATORIES
・       TABLE 143...... BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
・       FIGURE 41.. BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020)
13.1.13         QIAGEN
・       TABLE 144................................... QIAGEN: BUSINESS OVERVIEW
・       FIGURE 42.................. QIAGEN N.V.: COMPANY SNAPSHOT (2020)
13.1.14         GRIFOLS S.A.
・       TABLE 145............................ GRIFOLS S.A.: BUSINESS OVERVIEW
・       FIGURE 43................. GRIFOLS S.A.: COMPANY SNAPSHOT (2020)
13.1.15         ORTHO CLINICAL DIAGNOSTICS.. 222
・       TABLE 146.... ORTHO CLINICAL DIAGNOSTICS: BUSINESS OVERVIEW
・       FIGURE 44.... ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT (2020)
13.1.16         SYSMEX CORPORATION
・       TABLE 147.............. SYSMEX CORPORATION: BUSINESS OVERVIEW
・       FIGURE 45.... SYSMEX CORPORATION: COMPANY SNAPSHOT (2020)
13.2          OTHER PLAYERS
13.2.1            LUMINEX CORPORATION
13.2.2            MERIDIAN BIOSCIENCE
13.2.3            TRINITY BIOTECH.. 233
13.2.4            CHEMBIO DIAGNOSTIC SYSTEMS
13.2.5            ORASURE TECHNOLOGIES
13.2.6            SEEGENE
13.2.7            CO-DIAGNOSTICS
13.2.8            GENETIC SIGNATURES
13.2.9            EPITOPE DIAGNOSTICS
13.2.10         TRIVITRON HEALTHCARE
13.2.11         ELITECHGROUP
13.2.12         MERIL LIFESCIENCES PVT. LTD. 252
13.2.13         INBIOS INTERNATIONAL
13.2.14         ABACUS DIAGNOSTICA OY
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, RIGHT TO WIN MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
14.. APPENDIX

当レポートのプレスリリースは発行されておりません。